Back to URGN
Hennion & Walsh Asset Management, Inc. → URGN
Hennion & Walsh Asset Management, Inc. URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
5
Latest value
$12.6M
Q3 2026
Peak value
$12.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.3M |
| Q4 2025 | $3.8M |
| Q1 2026 | $3.3M |
| Q2 2026 | $10.2M |
| Q3 2026 | $12.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $12.6M | 309.6K | — | — |
| Q2 2026 | $10.2M | 276.7K | — | — |
| Q1 2026 | $3.3M | 183.5K | — | — |
| Q4 2025 | $3.8M | 161.9K | — | — |
| Q3 2025 | $1.3M | 65.2K | — | — |
Other funds holding URGN
$93.6M
$57M
$57M
$48M
$48M
$45M